U.S. Tobacco Stock News

Why Stepan’s latest earnings matter for shareholders Stepan (SCL) just released fourth quarter and full year 2025 results, pairing higher quarterly sales and net income with a goodwill impairment charge and a reaffirmed quarterly cash dividend of $0.395 per share. This mix of earnings, impairment and dividend news gives you a fresh look at how the chemical producer is balancing reported profitability, balance sheet adjustments and ongoing cash returns to shareholders. See our latest analysis...

AutoZone, Inc. reported past second-quarter 2026 results showing sales rising to US$4,274.10 million from US$3,952.01 million a year earlier, while net income eased to US$468.86 million and diluted EPS from continuing operations slipped to US$27.63. Alongside these mixed results, AutoZone continued its long-running capital return program, repurchasing 85,000 shares for US$310.80 million and bringing total buybacks since 2008 to about US$32.36 billion. Next, we'll examine how rising sales but...

AnaptysBio (ANAB) has drawn fresh attention after reporting a fourth quarter earnings swing to net income of US$49.61 million, supported by collaboration revenues and milestone payments tied to cancer drug Jemperli. See our latest analysis for AnaptysBio. The strong earnings swing and Jemperli related revenues arrive after a sharp rerating in the shares. The current US$55.41 price follows a 24.49% 90 day share price return and a 1 year total shareholder return of 239.11%, suggesting momentum...

In late February and early March 2026, analysts including Citi, Raymond James, and Barclays turned more cautious on American Homes 4 Rent, citing softer rental demand, elevated new supply, and rising concessions across single-family and multifamily markets. At Citi’s Miami Global Property CEO Conference 2026, American Homes 4 Rent outlined its response with a new US$500 million share repurchase authorization and plans to develop about 1,900 homes in 2026 while closely tracking legislative...

Graham Holdings Company recently reported its fourth-quarter and full-year 2025 results, with quarterly sales edging up to US$1,251.02 million while net income and earnings per share from continuing operations fell sharply year over year, alongside US$10.10 million of impairment charges on intangible and other long-lived assets. The company’s decision to maintain a regular quarterly dividend of US$1.88 per share, even as full-year net income dropped significantly, highlights a continued...

Lindsay (LNN) has rolled out two new road safety products, the Road Runner Truck Mounted Attenuator and the AlphaGuard channelizing device, giving investors fresh information on its infrastructure focused portfolio. See our latest analysis for Lindsay. The recent product launches come as Lindsay's 90 day share price return of 9.67% and year to date share price return of 6.97% contrast with a 1 year total shareholder return of 0.72% decline, suggesting shorter term momentum has picked up after...

Quarterly earnings and dividend catch investors’ attention Smith & Wesson Brands (SWBI) recently reported third quarter results alongside a fresh dividend announcement. This gives investors new data on both operating performance and direct cash returns. For the quarter ended January 31, 2026, sales were US$135.71 million compared with US$115.89 million a year earlier, while net income was US$3.75 million versus US$2.10 million. See our latest analysis for Smith & Wesson Brands. The earnings...

In February 2026, RLI Corp. completed a US$299.93 million fixed-rate senior unsecured notes offering, issuing 5.375% callable notes due June 1, 2036, alongside an amended and restated credit agreement with PNC Bank that extended maturity and expanded committed capacity. This combination of long-dated debt and enhanced bank financing reshapes RLI’s capital structure, potentially giving management more room to fund growth projects and manage liquidity across insurance cycles. Next, we’ll...

Nurix Therapeutics recently amended its equity distribution agreement to allow sales of up to US$413.65 million of common stock through Piper Sandler under its existing shelf registration. This expanded at-the-market facility gives Nurix added funding flexibility, potentially affecting how investors assess its balance between capital needs and ownership dilution. We will now examine how this enlarged at-the-market capacity shapes Nurix’s investment narrative, particularly around funding...

In February 2026, Atlas Energy Solutions reported fourth-quarter 2025 revenue of US$249.43 million and a quarterly net loss of US$22.24 million, while full-year 2025 revenue rose to US$1.10 billion alongside a full-year net loss of US$50.30 million versus a profit the year before. Despite swinging to losses, Atlas highlighted record utilization of its Dune Express system and new initiatives in power generation aimed at broadening its revenue base beyond traditional sand and logistics. We’ll...

In February 2026, Viridian Therapeutics reported fourth-quarter and full-year 2025 results showing modest revenue of US$132,000 for the quarter and US$70.85 million for the year, alongside higher net losses, while also filing a US$16.33 million common stock shelf registration tied to an ESOP-related offering and presenting at a major healthcare conference. Beyond the financials, investor attention centers on Viridian’s progress toward potential FDA approval and commercial launch preparations...

What triggered the latest move in Distribution Solutions Group? Distribution Solutions Group (DSGR) is back in focus after its fourth quarter and full year 2025 earnings missed analyst expectations on both revenue and earnings, pressuring margins and sparking legal scrutiny following a sharp share price reaction. See our latest analysis for Distribution Solutions Group. The sharp post earnings drop has fed into a wider reset in expectations, with a 7 day share price return of 26.12% and a...

What just happened with Genworth Financial stock Genworth Financial (GNW) has drawn fresh attention after reporting fourth quarter and full year 2025 results, as well as completing a share buyback that retired more than 10 million shares. See our latest analysis for Genworth Financial. At a share price of US$8.43, Genworth’s short term share price returns, including a 1 month share price return of 6.64% decline and a year to date share price return of 6.02% decline, contrast with a 1 year...

In late February 2026, Vir Biotechnology announced a global collaboration with Astellas Pharma around its investigational prostate cancer therapy VIR-5500, alongside positive early Phase 1 data, a US$150,000,002 follow-on equity raise, new shelf registration and its 2025 earnings results. Together, the Astellas partnership economics, encouraging early VIR-5500 data and fresh equity capital appear to materially reshape Vir Biotechnology’s funding mix, oncology profile and long-term...

Why Immunovant is back on investors’ radar Immunovant (IMVT) has drawn fresh attention after completing enrollment in a potentially registrational IMVT-1402 trial for difficult rheumatoid arthritis, alongside a roughly US$550 million capital raise from institutional investors. See our latest analysis for Immunovant. At a share price of US$26.66, Immunovant has recently seen a 15.06% 90 day share price return and a 33.17% 1 year total shareholder return. This suggests momentum has built over...

Pentair stock snapshot and recent performance Pentair (PNR) has been on many watchlists after a period of weaker share performance, with the stock showing negative returns over the past week, month, and past 3 months despite a positive 1 year total return. See our latest analysis for Pentair. At a share price of $92.17, Pentair’s recent 1 day, 7 day and 90 day share price returns have been negative, while its 1 year and 3 year total shareholder returns remain positive, suggesting shorter term...

In February 2026, Agilent Technologies reported first-quarter 2026 sales of US$1,798 million, with net income of US$305 million, and raised full-year 2026 revenue guidance to a range of US$7.30 billion to US$7.50 billion while issuing new second-quarter revenue guidance of US$1,790 million to US$1,820 million. Management’s decision to increase full-year revenue guidance while first-quarter earnings per share were slightly lower than a year earlier highlights confidence in cost control and...

In early March 2026, Mobix Labs, Inc. reported new production purchase orders for its high-reliability electromagnetic interference protection components used in Gulfstream business jets and the U.S. Navy’s Tomahawk cruise missile program, alongside a change to its bylaws reducing the shareholder meeting quorum requirement to one-third of voting power. The fresh aerospace and defense orders underline Mobix Labs’ role as an already-qualified supplier embedded in mission-critical platforms...

NIQ Global Intelligence: Recent Price Moves and Business Snapshot NIQ Global Intelligence (NIQ) has drawn fresh attention after recent share price swings, with the stock down 2.5% over the past day, weaker over the past week, but positive over the past month. For investors looking at the consumer data and analytics space, NIQ sits in an interesting position. The company reports annual revenue of US$4,198.4m and a net loss of US$353.3m, while its value score stands at 6. Over the past 3...

The weak February U.S. jobs report, which showed a loss of 92,000 jobs and unemployment at 4.4%, triggered a 3.6% drop in Enova International (ENVA), highlighting investor concern around credit conditions and demand. See our latest analysis for Enova International. That jobs-driven drop comes after a tougher few weeks for the share price, with a 30 day share price return of a 14.6% decline and a year to date share price return of a 15.05% decline, even though the 1 year total shareholder...

If you are wondering whether Casella Waste Systems at around US$94.03 is a fair deal or a stretch, you are not alone. This article focuses squarely on what the current price might imply about value. The stock has moved 0.9% over the past week, while showing a 10.1% decline over 30 days, a 4.7% decline year to date, a 16.4% decline over 1 year, but gains of 24.7% over 3 years and 45.3% over 5 years. Recent price moves sit against a backdrop where investors are watching the waste and recycling...

Federal Signal (NYSE:FSS) reported record quarterly and full year results, with net sales and adjusted EPS at the highest levels in the company’s history. The company announced a meaningful dividend increase alongside these results. Federal Signal also appointed two experienced executives to its board of directors. Federal Signal, listed on the NYSE under ticker FSS, focuses on safety and environmental solutions, including equipment and systems used by municipal, industrial, and commercial...

Garmin (NYSE:GRMN) reported record revenue across all segments. The company announced a 17% increase in its dividend. Garmin unveiled a new US$500 million share repurchase program. The company launched an initiative to recognize local changemakers in running communities. Garmin is best known for its GPS, fitness, aviation, marine, and outdoor products. All its business segments are contributing to record revenue. For investors, the combination of diversified end markets and demand for...

If you are wondering whether Planet Fitness is starting to look interesting at current levels, you are not alone. A closer look at what you are paying for the business can help put the recent share price in context. The stock closed at US$78.66, with returns of a 4.2% decline over 7 days, a 14.1% decline over 30 days, a 28.3% decline year to date and a 19.2% decline over 1 year, which may have some investors rethinking both the risk and potential reward here. Recent news has focused on...